Messages with direct wording and limited data points performed best in a new ZoomRx physician study. (c/o ZoomRx)

On­col­o­gists re­spond best to short, pre­cise and da­ta-rich mar­ket­ing mes­sages, study finds

Look­ing to get an on­col­o­gist’s at­ten­tion with a brand­ed drug mes­sage? Keep it short and sim­ple, but don’t for­get the da­ta. That’s some of the ad­vice emerg­ing from Zoom­Rx’s deep dive in­to on­col­o­gy mar­ket­ing mes­sag­ing to health­care pro­fes­sion­als.

Mes­sages that con­tained 10-14 words were found to be the most ef­fec­tive, which was mea­sured in the study as a com­pos­ite of how mo­ti­vat­ing, dif­fer­en­ti­at­ed and be­liev­able the mes­sages were.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.